Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
When do you offer high-dose vitamin D for patients with multiple sclerosis with normal serum levels?
In light of publication from
Thouvenot et al in JAMA
Related Questions
When would you use ofatumumab for anti-NMDAR autoimmune encephalitis?
When should MOG-Ab be tested in patients with suspected autoimmune encephalitis with seizures and normal MRI?
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?
How do you handle medication management for patients on immunosuppressive therapy who are lost to follow-up?
In a patient with prior biopsy-proven IgG4-related pachymeningitis who develops recurrent neurologic symptoms years after discontinuing immunosuppression, how do you determine whether this represents relapse versus alternative etiologies?
How do you interpret conflicting findings on CSF immunoglobulin tests for work up of multiple sclerosis and its mimics?
What is the role of skin biopsy for evaluating small fiber neuropathy in patients with rheumatic disease who have treatment recalcitrant pain?
When would you obtain optic nerve testing in patients suspected to have multiple sclerosis without a clinical history of optic neuritis?
What is your approach to treatment when there is a multiple sclerosis reactivation while on natalizumab?